Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study.

Saved in:
Bibliographic Details
Title: Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study.
Authors: Braun MR; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA., Moore AC; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA.; School of Biochemistry and Cell Biology, University College Cork, T12 XF62 Cork, Ireland.; National Institute of Bioprocessing Research and Training, A94 X099 Dublin, Ireland., Lindbloom JD; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA., Hodgson KA; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA., Dora EG; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA., Tucker SN; Vaxart Inc., 170 Harbor Way Suite 300, South San Francisco, CA 94080, USA.
Source: Vaccines [Vaccines (Basel)] 2024 Aug 23; Vol. 12 (9). Date of Electronic Publication: 2024 Aug 23.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines12090955